Silva-Pilipich, N.; Martisova, E.; Ballesteros-Briones, M.C.; Hervas-Stubbs, S.; Casares, N.; González-Sapienza, G.; Smerdou, C.; Vanrell, L.
Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity. Biomedicines 2020, 8, 562.
https://doi.org/10.3390/biomedicines8120562
AMA Style
Silva-Pilipich N, Martisova E, Ballesteros-Briones MC, Hervas-Stubbs S, Casares N, González-Sapienza G, Smerdou C, Vanrell L.
Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity. Biomedicines. 2020; 8(12):562.
https://doi.org/10.3390/biomedicines8120562
Chicago/Turabian Style
Silva-Pilipich, Noelia, Eva Martisova, María Cristina Ballesteros-Briones, Sandra Hervas-Stubbs, Noelia Casares, Gualberto González-Sapienza, Cristian Smerdou, and Lucia Vanrell.
2020. "Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity" Biomedicines 8, no. 12: 562.
https://doi.org/10.3390/biomedicines8120562
APA Style
Silva-Pilipich, N., Martisova, E., Ballesteros-Briones, M. C., Hervas-Stubbs, S., Casares, N., González-Sapienza, G., Smerdou, C., & Vanrell, L.
(2020). Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity. Biomedicines, 8(12), 562.
https://doi.org/10.3390/biomedicines8120562
